Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Faron Pharmaceuticals Oy | Helsinki | Healthcare | Biotechnology & Medical Research | €359.35M | -9.9x | -0.34 | €2.85 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -14.7% Downside | Upgrade to Pro+ | |
Nightingale Health Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €180.45M | -9.6x | -1.93 | €2.91 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3% Downside | Upgrade to Pro+ | |
Solar Foods Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €163.58M | -8.6x | 3.84 | €6.54 | 6.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -30.8% Downside | Upgrade to Pro+ | |
Nanoform Finland Plc | Helsinki | Healthcare | Biotechnology & Medical Research | €95.79M | -3.7x | 0.64 | €1.09 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Herantis Pharma Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €35.18M | -6x | 0 | €1.47 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.9% Upside | Upgrade to Pro+ |